Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Regulatory News:
The interim report for the first quarter 2013 was approved by the Board of Directors on 14 May 2013. Please find the interim report and presentation attached. Highlights from the report:
· On 7 March 2013 DiaGenic raised NOK 30 million in gross proceeds through a private placement of 50 million new shares at a price of NOK 0.60 per share. Registration of the private placement took place after the end of the quarter and the cash balance at the end of March was NOK 9.5 million
Help employers find you! Check out all the jobs and post your resume.
